Michele Zappella was an Italian child neurologist and psychiatrist who spent his career at the University of Siena making original contributions to the clinical understanding of autism spectrum disorders and related developmental conditions, developing assessment and treatment approaches that were recognised internationally, and identifying the clinical variant of Rett syndrome that the scientific community named the Zappella Variant in his honour, the formal recognition that his clinical observations had added a distinct and important phenotype to the understanding of the condition. He died in 2026.
He was born in Italy in the mid-twentieth century and pursued medical training in neurology and psychiatry, entering the clinical fields whose understanding of childhood developmental conditions was being fundamentally developed during the decades of his professional formation. Autism, first described by Leo Kanner in 1943 and separately by Hans Asperger in 1944, was a diagnosis whose clinical boundaries, underlying causes, and appropriate treatment approaches remained contested and incompletely understood across the decades of his career, and the practitioners who made real contributions to the field in the postwar period did so in a context of genuine scientific uncertainty and active clinical development. The work of identifying distinct presentations within the autism spectrum, understanding the neurological basis of different developmental conditions, and developing effective interventions for children with these conditions was the work of clinicians who combined careful observation, rigorous documentation, and intellectual engagement with a field that was constantly advancing.
Rett syndrome, the neurodevelopmental condition that primarily affects girls and that is characterised by early normal development followed by regression, loss of speech, stereotyped hand movements, and breathing irregularities, was described in the 1960s by Andreas Rett and gained wider scientific attention following a 1983 paper by Bengt Hagberg and colleagues that drew attention to the clinical characteristics of the syndrome across a larger patient series. The subsequent decades of research established the genetic basis of the condition in mutations of the MECP2 gene, identified in 1999 by Huda Zoghbi, and developed a more refined understanding of the spectrum of presentations that Rett syndrome encompasses. His identification of a milder variant of the condition, characterised by preserved speech, less severe motor regression, and better functional outcomes than the classic form of Rett syndrome, added an important dimension to the clinical picture of the condition and provided families and clinicians with a more accurate prognosis for children with this presentation.
His work at the University of Siena encompassed both clinical practice and the teaching and research programmes that gave his contributions a reach beyond the individual patients he treated. The practitioners who trained under his supervision at Siena carried his approaches and perspectives into their own clinical practices across Italy and contributed to the broader development of child neuropsychiatry in the country. His publications in international scientific journals made his clinical findings available to the global research and clinical community and positioned his contributions within the wider scientific conversation about autism and Rett syndrome that has continued to advance across the decades of his career.
He also wrote extensively for clinical and popular audiences about autism, advocating for early intervention approaches and for a more nuanced understanding of autism spectrum presentations that recognised the individual strengths and needs of children with these conditions rather than defining them solely by their disabilities. His death in 2026 ended the active career of one of Italy’s most important contributions to the international clinical understanding of childhood developmental conditions.